Saltar al contenido
Merck
  • IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation.

IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation.

The Journal of experimental medicine (2013-03-06)
Lue Dai, Kristy B Lidie, Qian Chen, Joseph W Adelsberger, Xin Zheng, DaWei Huang, Jun Yang, Richard A Lempicki, Tauseef Rehman, Robin L Dewar, Yanmei Wang, Ronald L Hornung, Kelsey A Canizales, Stephen J Lockett, H Clifford Lane, Tomozumi Imamichi
RESUMEN

The susceptibility of macrophages to HIV-1 infection is modulated during monocyte differentiation. IL-27 is an anti-HIV cytokine that also modulates monocyte activation. In this study, we present new evidence that IL-27 promotes monocyte differentiation into macrophages that are nonpermissive for HIV-1 infection. Although IL-27 treatment does not affect expression of macrophage differentiation markers or macrophage biological functions, it confers HIV resistance by down-regulating spectrin β nonerythrocyte 1 (SPTBN1), a required host factor for HIV-1 infection. IL-27 down-regulates SPTBN1 through a TAK-1-mediated MAPK signaling pathway. Knockdown of SPTBN1 strongly inhibits HIV-1 infection of macrophages; conversely, overexpression of SPTBN1 markedly increases HIV susceptibility of IL-27-treated macrophages. Moreover, we demonstrate that SPTBN1 associates with HIV-1 gag proteins. Collectively, our results underscore the ability of IL-27 to protect macrophages from HIV-1 infection by down-regulating SPTBN1, thus indicating that SPTBN1 is an important host target to reduce HIV-1 replication in one major element of the viral reservoir.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Spectrin from human erythrocytes, buffered aqueous glycerol solution